Late thrombosis a concern with drug-eluting stents

Journal of Interventional Cardiology

Volumn 20, Issue 1, 2007, Pages 26-29

  Leon, Martin B ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; FIBRIN; PACLITAXEL; POLYMER; RAPAMYCIN;

ACUTE HEART INFARCTION; BRACHYTHERAPY; CLINICAL TRIAL; COMPARATIVE STUDY; DIABETES MELLITUS; DISEASE COURSE; DRUG ELUTING STENT; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; EOSINOPHIL; FIBRIN FORMATION; HEART LEFT VENTRICLE EJECTION FRACTION; HIGH RISK POPULATION; HUMAN; HYPERSENSITIVITY REACTION; ILIAC ARTERY; IMPLANTATION; IN-STENT RESTENOSIS; INCIDENCE; INFLAMMATION; KIDNEY FAILURE; MORTALITY; OUTCOME ASSESSMENT; PATIENT SAFETY; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STENT; THERAPY RESISTANCE; THROMBOSIS; TREATMENT RESPONSE; WOUND HEALING IMPAIRMENT;

CORONARY DISEASE; CORONARY THROMBOSIS; DRUG DELIVERY SYSTEMS; HUMANS; STENTS;

EID: 33846537511     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2007.00225.x     Document Type: Review

References (15)

1. Leon MB. DES failures: Stent thrombosis (early and late) and restenosis. Paper presented at the 12th Annual Interventional Fellow's Course, San Jose, CA, March 30, 2006.
2. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-2130.
3. Kernis SJ, et al. Clinical outcomes associated with use of drug-eluting stents compared with bare-metal stents for primary percutaneous intervention (PREMIER registry). Paper presented at the Annual Transcatheter Cardiovascular Therapeutics Symposium, Washington, DC, October 20, 2005.
4. Spaulding CH. Trial to assess the use of the Cypher stent in acute myocardial infarction treated with balloon angioplasty (TYPHOON). Paper presented at the American College of Cardiology 2006 Scientific Sessions; Atlanta, GA, March 12, 2006.
5. McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004; 364:1519-1521.
6. Ong ATL, Hoye A, Aoki J, et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 2005; 45:947-953.
7. Pfisterer ME. Basel stent cost-effectiveness trial - Late thrombotic events (BASKET-LATE). Paper presented at the American College of Cardiology Scientific Sessions, Atlanta, GA, March 14, 2006.
8. Moreno R, Fernandez C, Hernandez R, et al. Drug-eluting stent thrombosis: Results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 2005;45:954-959.
9. Kuchulakanti PK, Chu WW, Torguson R, et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimusand paclitaxel-eluting stents. Circulation 2006;113:1108-1113.
10. Virmani R, Guagliumi G, Farb A, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: Should we be cautious? Circulation 2004;109:701-705.
11. Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202.
12. Finn AV, Kolodgie FK, Harnek J, et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 2005;112:270-278.
13. Nguyen TA, Diodati JG, Pharand C. Resistance to clopidogrel: A review of the evidence. J Am Coll Cardiol 2005;45:1157-1164.
14. Gum PA, Kottke-Marchant K, Welsh PA, White J, Topol EJ. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 2003;41:961-965.
15. Wenaweser P, Dorffler-Melly J, Imboden K, et al. Stent thrombosis is associated with an impaired response to antiplatelet therapy. J Am Coll Cardiol 2005;45:1748-1752.